跳至主要内容

Year-Round Parasite Control for Grazing Cattle: A 5-Time Deworming Schedule

Parasitic infections pose a significant threat to the health and productivity of grazing cattle, especially in rural settings where preventive measures are often overlooked. Regular deworming is essential to combat internal and external parasites that can lead to weight loss, anemia, poor growth, and even death. This article outlines a science-backed, five-time deworming schedule tailored for rural free-range cattle, ensuring optimal health throughout the year.


Why Deworming Matters

Cattle, particularly those raised in open pastures, are vulnerable to a range of parasites:

  • Internal parasites​ (e.g., roundworms, liver flukes) damage the digestive system and reduce nutrient absorption.
  • External parasites​ (e.g., ticks, lice, mites) cause skin irritation, blood loss, and transmit diseases.
  • Bloodborne parasites​ like Babesia (causing babesiosis or “cattle fever”) can be fatal if untreated.

Untreated infestations weaken immunity, stunt growth, and lower meat/milk production. Proactive deworming is critical to maintaining herd health and profitability.


5 Key Deworming Times for Optimal Results

1. Early Spring (March–April): Foundation for Growth

  • Objective: Clear parasites before spring grazing begins.
  • Method:
    • Ivermectin injection​ (targets lungworms, gastrointestinal worms, and external parasites).
    • Albendazole oral drench​ (eliminates liver flukes and tapeworms).
  • Why this combo?​​ Ivermectin tackles both internal and external threats, while albendazole ensures deeper gut clearance.

2. Midsummer (June–July): Battle External Pests

  • Objective: Combat ticks, lice, and mites plaguing warm-season pastures.
  • Method:
    • 0.1% Ivermectin pour-on​ or ​0.1% Amitraz spray​ (effective against ectoparasites).
    • Repeat sprays every 2–3 weeks if infestation persists.
  • Tip: Treat all animals simultaneously to prevent reinfestation.

3. Late Summer (August): Guard Against Blood Parasites

  • Objective: Target Babesia and other hemoprotozoa during peak transmission.
  • Method:
    • Imidocarb dipropionate injection​ (curative for babesiosis).
    • Diminazene diaceturate​ (alternative for resistant strains).
  • Note: Blood tests may be needed to confirm infections before treatment.

4. Post-Monsoon (August–September): Liver Fluke Focus

  • Objective: Address Fasciola hepatica outbreaks in wet, marshy pastures.
  • Method:
    • Triclabendazole​ (most effective against adult liver flukes).
    • Clorsulon​ (for immature flukes).
  • Prevention: Fence off swampy areas or use flukicidal drugs prophylactically.

5. Pre-Winter (October–November): Boost Immunity

  • Objective: Ensure robust health before colder months reduce forage quality.
  • Method:
    • Ivermectin injectable + Fenbendazole oral​ (broad-spectrum coverage).
    • Rotate dewormers annually to prevent resistance.


Critical Considerations for Success

  1. Rotate Dewormers: Avoid overusing a single drug class (e.g., macrocyclic lactones like ivermectin) to delay resistance.
  2. Weight-Based Dosing: Use a scale or weigh tape for accuracy—underdosing reduces efficacy.
  3. Safety Protocols: Wear gloves when handling dips/sprays, and avoid exposure to treated animals for 24–48 hours.
  4. Monitor Efficacy: Conduct fecal egg counts 10–14 days post-treatment to assess success.
  5. Veterinary Guidance: Tailor protocols to local parasite prevalence and resistance patterns.

Final Thoughts

A strategic five-time deworming program—aligned with seasonal risks—can dramatically improve cattle health, productivity, and longevity. By combining science-backed treatments with vigilant management, farmers can protect their herds from hidden threats lurking in pastures and guts alike. Always consult a veterinarian for region-specific advice!


Key Takeaway: Don’t wait for symptoms—proactive, scheduled deworming is the cornerstone of profitable and sustainable cattle farming.

Kaifeng Darui Pharmaceutical Co., Ltd.

Kaifeng Darui Pharmaceutical Co., Ltd.

Dedicated to high-end pharmaceutical raw materials, food additives, and intermediates.

About Us

Kaifeng Darui Pharmaceutical Co., Ltd., established on June 19, 2020, with a registered capital of 27 million RMB, is a high-tech enterprise located in the Kaifeng Fine Chemical Industrial Park. We focus on the R&D, production, and sales of high-end pharmaceutical raw materials, food additives, and intermediates.

We are a professional GMP-certified manufacturer of veterinary non-sterile APIs, strictly adhering to veterinary GMP requirements in design and construction. Our facility boasts a clean production environment and a rational layout.

We uphold the concept of green development, emphasizing talent and team building to achieve sustainable and healthy growth.

Financial Highlights:

  • 2023 Total Output Value: 44 million RMB, Tax Contribution: 1.45 million RMB.
  • 2024 Total Output Value: Over 60 million RMB, Tax Contribution: 2 million RMB.

Company Philosophy: "Survive by quality, root in talent; develop by technology, benefit from management." We persistently pursue excellent quality and a perfect brand and corporate image.

Research & Development

Since our inception, we established a dedicated technical team for R&D and technology introduction. Currently, we employ over 100 staff, with more than 20 R&D professionals (over 20% of workforce). Over 70% hold college degrees or higher, including 2 senior engineers, 2 associate professors, 1 lecturer, and 4 intermediate engineers.

We possess an independent R&D center (320 sq meters) with professional chemical laboratories and dedicated testing/analysis units. Our equipment includes HPLC, GC, UV-Vis Spectrophotometers, analytical balances, moisture analyzers, etc.

We collaborate closely with domestic universities and research institutions like Henan Academy of Sciences Chemical Research Institute Co., Ltd., Pingdingshan University, and Xinxiang Medical University to foster industry-university-research cooperation.

Facilities

Our plant is designed and built according to "Veterinary Drug Manufacturing Quality Management Standards".

  • Non-sterile API workshop (700 sq meters) with synthesis and refining/drying/packaging sections.
  • Two production lines with separate air purification systems; clean areas meet Class D standards.
  • Standardized production workshops, distillation equipment, 150 t/d wastewater treatment facility, and RCO exhaust gas treatment unit.
  • Water production equipment and air conditioning/purification systems.
  • Warehousing: Raw/auxiliary material, finished product, packaging material, and special management finished product warehouses.

Qualifications & Honors

  • High-tech Enterprise Certification (2023).
  • Henan Province Innovative Small and Medium-sized Enterprise (Dec 2022).
  • Kaifeng City Alkane Bromination Product Engineering Technology Research Center (2023).
  • Loving Charity Enterprise Title (Jan 2023).
  • Kaifeng Pharmaceutical Industry Association Council Member (Since 2021), Chairman Yang Xiaoke appointed as Council Director (Jan 2024).
  • Veterinary Drug Production License and 18 API GMP Certificates from Henan Provincial Department of Agriculture and Rural Affairs (Nov 2024).

Intellectual Property

We emphasize technological innovation and transformation. As of the report date, we hold 12 utility model patents, with 4 applications pending. These patents enhance our independent innovation capabilities and promote the transformation of scientific achievements.

Products & Services / Cooperation

Focus Areas:

  • Fine Chemicals & APIs
  • Food Additives
  • Fine Chemical & Pharmaceutical Intermediates

Areas for Cooperation:

  • Development of new veterinary and pet APIs.
  • Development of new food additives.
  • Cooperation on key production technologies, development and application of fine chemicals and pharmaceutical intermediates.

Future Outlook & Industry Prospects

As a certified High-tech Enterprise, we aim to standardize R&D project management, enhance innovation, and follow the growth path of quality SMEs (Sci-tech SME, Innovative SME, "Specialized, Refined, Unique, New" SME, Sci-tech Little Giant).

Key Development Directions:

  • Leveraging alkane bromination technology, establishing a national-level R&D, demonstration, training, pilot testing, and cooperation base.
  • Strengthening high-value-added biomedical fine products based on existing antiviral and anthelmintic products through R&D and university collaborations.
  • Continuing focus on veterinary APIs, capitalizing on the growing pet market, expanding livestock farming needs, and increasing international competitiveness and export opportunities for Chinese veterinary APIs.

Three-Year Goal (Targeting 2025): Achieve 100 million RMB in production and sales value, increase R&D investment to 20 million RMB, develop 2-3 new products annually, and attain the "Specialized, Refined, Unique, New" enterprise status.

© Kaifeng Darui Pharmaceutical Co., Ltd. All rights reserved.

Contact Us

Address: Kaifeng Fine Chemical Park, Henan, China

Tel: +86-13837178289

Email: [email protected]